Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
—
across known amounts
Stages
—
Portfolio
No portfolio companies in this dataset yet.
Investor Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Abingworth's primary investment focus based on its portfolio?
- Abingworth primarily focuses on the Health Tech & Life Sciences sector, as indicated by all of its portfolio companies and investment rounds.
- Can you name some notable companies in Abingworth's portfolio?
- Abingworth's portfolio includes Teva Pharmaceuticals and Chiasma. For a full list, refer to startupim data.
- What is Abingworth's investment range?
- Abingworth's investment range is between $33.5M and $150M per round.
- Has Abingworth led any investment rounds?
- Yes, Abingworth led an investment round for Teva Pharmaceuticals in April 2024, amounting to $150M.
- When did Abingworth make its first recorded investment?
- Abingworth's first recorded investment was in December 2014.
- What is a significant exit for Abingworth?
- A significant exit for Abingworth was the IPO of Chiasma on NASDAQ in July 2015, with a valuation of $562M.
- What types of funding stages has Abingworth participated in?
- Abingworth has participated in D Round, E Round, and PIPE funding stages.
- How many new portfolio companies did Abingworth add in 2024?
- Abingworth added one new portfolio company in April 2024, which was Teva Pharmaceuticals.